CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Successful Rechallenge with Gefitinib for an Initial Erlotinib-Responder with Advanced Lung Adenocarcinoma.
Sung Chul Hong, Yun Su Sim, Jin Hwa Lee, Yon Ju Ryu, Jung Hyun Chang
Tuberc Respir Dis. 2011;71(4):286-290.   Published online October 1, 2011
DOI: https://doi.org/10.4046/trd.2011.71.4.286

Excel Download

Successful Rechallenge with Gefitinib for an Initial Erlotinib-Responder with Advanced Lung Adenocarcinoma
Tuberculosis and Respiratory Diseases. 2011;71(4):286   Crossref logo
Link1 Link2 Link3

Successful erlotinib rechallenge after both gefitinib- and erlotinib-induced interstitial lung diseases
Respirology Case Reports. 2013;n/a-n/a   Crossref logo
Link1 Link2

Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease
Cancer Chemotherapy and Pharmacology. 2009;65(4):803-806   Crossref logo
Link1 Link2 Link3

Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Thoracic Cancer. 2013;4(2):109-116   Crossref logo
Link1

Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature
Lung Cancer. 2012;77(2):464-468   Crossref logo
Link1 Link2

Successful Erlotinib Rechallenge in a Non-small Cell Lung Cancer Patient With Erlotinib-Induced Interstitial Lung Disease (ILD)
Chest. 2012;142(4):654A   Crossref logo
Link1 Link2

Successful Erlotinib Rechallenge after Gefitinib-Induced Acute Interstitial Pneumonia
Journal of Thoracic Oncology. 2010;5(7):1105-1106   Crossref logo
Link1 Link2

Successful Erlotinib Rechallenge After Erlotinib-Induced Interstitial Lung Disease
Journal of Thoracic Oncology. 2011;6(6):1142-1143   Crossref logo
Link1 Link2

Duration of prior gefitinib treatment predicts survival potential in patients with lung adenocarcinoma receiving subsequent erlotinib
Lung Cancer. 2011;73(2):211-216   Crossref logo
Link1 Link2

Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports
Thoracic Cancer. 2014;5(1):38-42   Crossref logo
Link1